Congestive Heart Failure with Anemia

Have you been told you have congestive heart failure with anemia? You may qualify for this study:

Red Heart Failure Study:  Principal Investigator: Nizar Saleh, MD

This study is examining the benefits of increasing the hemoglobin count in patients with congestive heart failure and anemia. The drug, Darbepoetin alfa, is currently FDA-approved for the treatment of anemia in patients with renal failure and patients undergoing chemotherapy with anemia. Congestive heart failure would be a new indication for this drug. Patients are initially screened for a low hemoglobin and if they qualify, go on to echo evaluation, iron deficiency studies and bi-monthly visits for injections. For more information call Cathy Neva at 218-786-4867.